Sugi Predict

Sugi Predict / Compounds / SCHEMBL13611503

SCHEMBL13611503

SCHEMBL13611503

CNC(=S)N/N=C/c1ccccn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 3/20 1.00
▸ L3MBTL1 Q9Y468 2/20 0.67
▸ CTH P32929 1/20 0.67
▸ HKDC1 Q2TB90 1/20 0.64
▸ SLC2A1 P11166 1/20 0.62
▸ ADORA2A P29274 1/20 0.59
▸ NPC1 O15118 4/20 0.56
▸ RAB9A P51151 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ LMNA P02545 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ KDM4E B2RXH2 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ MITF O75030 1/20 0.55
▸ HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31690655 0.90 TOP2A (0.82) TOP2AL3MBTL1CTHHKDC1SLC2A1
SCHEMBL31690665 0.84 TOP2A (0.73) TOP2AL3MBTL1CTHHKDC1SLC2A1
SCHEMBL5180987 0.84 TOP2A (1.00) TOP2AL3MBTL1CTHHKDC1SLC2A1
SCHEMBL5180992 0.84 TOP2A (1.00) TOP2AL3MBTL1CTHHKDC1SLC2A1
SCHEMBL11830724 0.82 TOP2A (0.69) TOP2AL3MBTL1CTHHKDC1SLC2A1
SCHEMBL2562207 0.81 TOP2A (0.68) TOP2AL3MBTL1CTHHKDC1SLC2A1
SCHEMBL534248 0.81 TOP2A (0.68) TOP2AL3MBTL1CTHHKDC1ADORA2A
SCHEMBL2562208 0.81 TOP2A (0.68) TOP2AL3MBTL1CTHHKDC1SLC2A1
SCHEMBL293101 0.81 TOP2A (0.68) TOP2AL3MBTL1CTHHKDC1ADORA2A
SCHEMBL1982234 0.80 CTH (1.00) TOP2AL3MBTL1CTHSLC2A1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140311381-A1 Cellulose Acylate Film SK INNOVATION CO., LTD. (KR) 2014-10-23 — — US disclosed
US-20140116293-A1 Optical Film SK INNOVATION CO., LTD. (KR) 2014-05-01 — — US disclosed
EP-2722356-A2 OPTICAL FILM SK Innovation Co., Ltd. (KR) 2014-04-23 — — EP disclosed
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators MAVS, IRF3, HAVCR2 TOP2A 2331/4885L3MBTL1 3722/4885CTH 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.